Contact Us  |  Site Map  |  Search  |  Client Login  
 
 
Boston Millennia Partners
   
  Boston Millennia Partners provides private equity financing to high growth companies in the healthcare and life sciences industry. Our team brings over one hundred years of combined private equity experience to the investment process. Our broad experience, combined with expertise in finance; operations; engineering; life sciences research and development; partnering with pharmaceutical companies; business development; executive recruiting; and law provides significant value to the companies in which we invest. Since the early 1980’s, members of our team have managed seven venture capital partnerships with very successful results for our investors and our entrepreneurs. The growth and success of our portfolio companies have, in turn, allowed us to grow and expand our capital base to over $700 million under management.  
 

Boston Millennia Partners is pleased to announce that its portfolio company, Odyssey Logistics & Technology Corporation, a leading global logistics provider, has achieved revenue growth in excess of 66% in 2011. Benefiting from solid organic growth as well as successfully integrating four recent acquisitions from April 2010 through January 2011, the Company is continuing its acquisition program in 2012. "Odyssey is benefiting from scale, as its larger transportation network enables it to lower costs to its customers. Also,” says Martin Hernon, a partner at Boston Millennia Partners and member of the Odyssey Board of Directors, “the company is an attractive acquisition partner for business owners, as Odyssey management strives to maintain a very fair and congenial culture for the companies that it acquires." Click Here to Read More


 
   
   

Collegium Announces FDA Acceptance of IND Application for Abuse-Deterrent, Hydrocodone DETERx®
Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that the U.S. Food and Drug Administration has accepted the Company’s investigational new drug application to begin a clinical trial of Hydrocodone DETERx®, an abuse-deterrent, extended-release analgesic for the treatment of chronic pain.

Learn More >

PAREXEL Announces Agreement to Acquire Health Advances
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, announces that the Company has entered into a definitive agreement to acquire all outstanding equity securities of Health Advances, LLC, an independent life sciences strategy consulting firm.

Learn More >

NICE Systems (NASDAQ: NICE) Agrees to Acquire BMP Portfolio Company, Nexidia, Inc., for $135 million
Millennia Portfolio Company, Nexidia, will be acquired by NICE Systems in a $135M transaction. NICE Systems is the worldwide leading provider of enterprise software solutions that empower organizations to make smarter decisions based on advanced analytics of structured and unstructured data.

Learn More >

Boston Millennia Partners Portfolio Company, Collegium Pharmaceutical, Inc., Announces a Public Offering of $55 Million of Common Stock
Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the pricing of its public offering of 2,750,000 shares of its common stock at a price to the public of $20.00 per share, before underwriting discounts and commissions. The gross proceeds of this offering are expected to be $55.0 million.

Learn More >

Millennia Portfolio Company, Collegium Pharmaceutical, Announces FDA Tentative Approval for Xtampza(TM) ER
Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announces that the United States Food and Drug Administration (FDA) has granted tentative approval to the Company's New Drug Application (NDA) for Xtampza™ ER (oxycodone) extended-release capsules.


Learn More >

Millennia Portfolio Company, MedAptus®, Announces Emerson Hospital Deploys MedAptus to Improve Charge Capture, Management Processes
MedAptus® announces Emerson Hospital has selected the company’s Pro Charge Capture technology for its inpatient medicine, pediatrics and behavioral health providers. These clinical end-users utilize the Pro solution while on rounds at both Emerson and Spaulding Rehabilitation Hospitals.

Learn More >

Bon Secours Richmond Health System Selects MedAptus to Automate Hospitalist Coding and Billing
MedAptus® announces that Bon Secours Richmond Health System has implemented the company's Pro Charge Capture technology for its adult hospitalist and pediatric hospitalist intensivist providers that deliver care at St. Mary’s Hospital.

Learn More >

Millennia Founders Fund Invests in Avhana Health
Boston Millennia's Founders Fund invests in the seed round of Avhana Health, a Maryland-based startup with a mission of developing the world's most robust clinical decision support platform.

Learn More >

Millennia Portfolio Company, MedAptus, Announces Kentucky Medical Services Foundation Selects "Enroll Solution" to Improve Overall Processes
MedAptus® announced Kentucky Medical Services Foundation, Inc. (KMSF) has contracted for the company’s Enroll offering, powered by Newport Credentialing Solutions, the nation’s premier provider of cloud-based credentialing workflow software and IT enabled services.

Learn More >

 
 
Click Here to receive news updates
from Boston Millennia Partners >



 
CEO Video Dana Callow on Bloomberg TV with Pimm Fox

Video: Click Here to View
CEO Video NECN CEO Corner Interview With Dana Callow

Video: Large | Small
CEO Video Dana Callow on PBS’s Greater Boston With Emily Rooney

Video: Large | Small
spacer
   
Healthcare information is becoming broadly available to consumers, which is expanding basic demand.
Learn More >
 
   
Three key areas of opportunity in the Life Sciences sector are drug discovery & development...
Learn More >
 
 
  | Our Firm      Our Team      Our Portfolio      Resources      News  
  © 2016 Boston Millennia Partners  All Rights Reserved